1. Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer. Manning HC, Merchant NB, Foutch AC, Virostko JM, Wyatt SK, Shah C, McKinley ET, Xie J, Mutic NJ, Washington MK, LaFleur B, Tantawy MN, Peterson TE, Ansari MS, Baldwin RM, Rothenberg ML, Bornhop DJ, Gore JC, Coffey RJ (2008) Clin Cancer Res 14(22): 7413-22
    › Primary publication · 19010858 (PubMed) · PMC2657180 (PubMed Central)
  2. Fibrocystin/polyductin modulates renal tubular formation by regulating polycystin-2 expression and function. Kim I, Fu Y, Hui K, Moeckel G, Mai W, Li C, Liang D, Zhao P, Ma J, Chen XZ, George AL, Coffey RJ, Feng ZP, Wu G (2008) J Am Soc Nephrol 19(3): 455-68
    › Primary publication · 18235088 (PubMed) · PMC2391052 (PubMed Central)
  3. EGF receptor-independent action of TGF-alpha protects Naked2 from AO7-mediated ubiquitylation and proteasomal degradation. Ding W, Li C, Hu T, Graves-Deal R, Fotia AB, Weissman AM, Coffey RJ (2008) Proc Natl Acad Sci U S A 105(36): 13433-8
    › Primary publication · 18757723 (PubMed) · PMC2527346 (PubMed Central)
  4. Zebrafish Naked1 and Naked2 antagonize both canonical and non-canonical Wnt signaling. Van Raay TJ, Coffey RJ, Solnica-Krezel L (2007) Dev Biol 309(2): 151-68
    › Primary publication · 17689523 (PubMed) · PMC2729589 (PubMed Central)
  5. Variability of in situ proteomic profiling and implications for study design in colorectal tumors. Li JQ, Xu BJ, Shakhtour B, Deane N, Merchant N, Heslin MJ, Washington K, Coffey RJ, Beauchamp RD, Shyr Y, Billheimer D (2007) Int J Oncol 31(1): 103-11
    › Primary publication · 17549410 (PubMed)
  6. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Kaiser S, Park YK, Franklin JL, Halberg RB, Yu M, Jessen WJ, Freudenberg J, Chen X, Haigis K, Jegga AG, Kong S, Sakthivel B, Xu H, Reichling T, Azhar M, Boivin GP, Roberts RB, Bissahoyo AC, Gonzales F, Bloom GC, Eschrich S, Carter SL, Aronow JE, Kleimeyer J, Kleimeyer M, Ramaswamy V, Settle SH, Boone B, Levy S, Graff JM, Doetschman T, Groden J, Dove WF, Threadgill DW, Yeatman TJ, Coffey RJ, Aronow BJ (2007) Genome Biol 8(7): R131
    › Primary publication · 17615082 (PubMed) · PMC2323222 (PubMed Central)
  7. Targeted imaging of colonic tumors in smad3-/- mice discriminates cancer and inflammation. Deane NG, Manning HC, Foutch AC, Washington MK, Aronow BJ, Aronow BA, Bornhop DJ, Coffey RJ (2007) Mol Cancer Res 5(4): 341-9
    › Primary publication · 17426249 (PubMed)
  8. Potentiation of oxyntic atrophy-induced gastric metaplasia in amphiregulin-deficient mice. Nam KT, Varro A, Coffey RJ, Goldenring JR (2007) Gastroenterology 132(5): 1804-19
    › Primary publication · 17484876 (PubMed)
  9. Oncogenic K-RAS subverts the antiapoptotic role of N-RAS and alters modulation of the N-RAS:gelsolin complex. Keller JW, Haigis KM, Franklin JL, Whitehead RH, Jacks T, Coffey RJ (2007) Oncogene 26(21): 3051-9
    › Primary publication · 17130841 (PubMed)
  10. Oncogenic KRAS provides a uniquely powerful and variable oncogenic contribution among RAS family members in the colonic epithelium. Keller JW, Franklin JL, Graves-Deal R, Friedman DB, Whitwell CW, Coffey RJ (2007) J Cell Physiol 210(3): 740-9
    › Primary publication · 17133351 (PubMed)